S. Frescas

发表

Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).

D. E. Nichols, D. Marona-Lewicka, D. Kurrasch-Orbaugh, 2002, Journal of medicinal chemistry.

1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist.

D. E. Nichols, B. Roth, D. Marona-Lewicka, 1994, Journal of medicinal chemistry.

Indan Analogs of Fenfluramine and Norfenfluramine Have Reduced Neurotoxic Potential

N. Cozzi, D. Marona-Lewicka, S. Frescas, 1998, Pharmacology Biochemistry and Behavior.

trans-2-(2,5-Dimethoxy-4-iodophenyl)cyclopropylamine and trans-2-(2,5-dimethoxy-4-bromophenyl)cyclopropylamine as potent agonists for the 5-HT2 receptor family

Xi-Ping Huang, B. Roth, J. McCorvy, 2012, Beilstein journal of organic chemistry.

A Facile Method for the Preparation of Pure cis‐2,4‐Pentanediol

S. Frescas, L. Bonner, D. Nichols, 2004 .

Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA).

M. P. Johnson, R. Oberlender, S. Frescas, 1991, Journal of medicinal chemistry.

High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand.

A. Lewin, S. Frescas, D. Nichols, 2008, Bioorganic & medicinal chemistry.

Synthesis and Pharmacological Examination of 1‐(3‐Methoxy‐4‐methylphenyl)‐2‐aminopropane and 5‐Methoxy‐6‐methyl‐2‐aminoindan: Similarities to 3,4‐(Methylenedioxy)methamphetamine (MDMA).

Michael P. Johnson, R. Oberlender, S. Frescas, 1991 .

A New, Simple Procedure for the Preparation of 8-Methoxy-2-Tetralone

S. Frescas, D. Nichols, Seongmin Lee, 1995 .